ER, I'm thinking there's some confusion as to what was

New Post Public Reply Private Reply Replies (0) Message Board
chuckles759 Evil Rabbit #107188
588
ER,

I'm thinking there's some confusion as to what was sent to the FDA. I'm thinking there's a very oddly worded Freedom of Information Act (FOIA) request sent back in Jan 2021. I think it was denied a response in Feb 2021.

Request is in this spreadsheet published on FDA's FOIA Logs under Control # 2021-266:
https://www.fda.gov/media/145544/download

The Request Denied status is reflected here:
https://www.fda.gov/media/146336/download

No reason for the "Request Denied" status.

I just find the wording odd in the request:
Quote:
The product at issue is a drug (not approved yet, still in clinics trials). The name of the drug is leronlimab, formerly pro-140. On August 17th, 2020, Cytodyn released a PR stating that the company had filed for Emergency Use Authorization (EUA) with the FDA for the COVID19 mild to moderate population using the data from their completed COVID19 M2M trial (CD10_COVID-19 or NCT04343651). I have reason to believe that Cytodyn misled investors and that the company did not file an EUA for the M2M indication. If possible, I would like a copy of the EUA filed by Cytodyn or if that?s not an option, an acknowledgment from the FDA that the organization either received the EUA from Cytodyn or that you didn?t receive the EUA.


The wording sounds like something you would submit to the SEC for a FOIA request. Why would you say that to the FDA when requesting FDA related information...

Quote:
I have reason to believe that Cytodyn misled investors


Sounds like someone with a bone to pick with the company....and not a positive one....

FYI: I did not see any requests by this name elsewhere in the FDA FOIA request logs, nor the SEC's logs. Hopefully they got it off their chest and didn't let it eat at their soul enough to go on a blind rampage trying to destroy people's reputations or a company's publicly traded stock by making false and misleading statements on a public forum when invested in a potentially hostile organization attempting a control takeover of CytoDyn.....

....that wouldn't be good form....

[late add] I hope everyone realizes that all these documents the US Government receives and responds to is public information...with the exception of Personally Identifiable Information.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Termite Swarmers: Essential Clues and Action Steps

Updated Category News Views 198

Understanding the Intrusive Nature of Termite Swarmers When it comes to creepy crawlies wreaking havoc on your beloved abode, termites are the stealthy troublemakers you need to keep an eye out for. Just because you catch a glimpse of them doesn't mean the damage is obvious or minimal. Spotting the Culprits: Termites vs. Ants Identifying what you're up against is the...

Continue Reading
Allegiant Overhauls Service with UNLV Training

Updated Category News Views 0

Allegiant Airlines and UNLV: A Unique Collaboration The world of airline customer service is about to get a shakeup, thanks to a new collaboration between Allegiant Airlines and the University of Nevada, Las Vegas' renowned William F. Harrah College of Hospitality. It's a partnership that aims to bring a new level of service to the skies, guided by some of the best minds...

Continue Reading
Sinopec Unveils Biodiversity Report at COP17

Updated Category News Views 30

Sinopec's First Step on the Global Biodiversity Stage Seems like Sinopec (HKG: 0386) has decided to toss its hat into the biodiversity conservation ring. At COP17 in Armenia, they released their inaugural Global Biodiversity Conservation Report—an event that marks more than just a company selling oil and gas. Now, they're talking wildlife and ecologies. Is that irony,...

Continue Reading
Muyang Group's High-Stakes Legal Battle Over Corporate Sabotage

Updated Category News Views 21

Decades of Corporate Drama Unfold in Court A pesky legal storm is brewing from the heart of Yangzhou, China, as Jiangsu Muyang Group battles former execs in a lawsuit that reeks of corporate intrigue. You can't make this stuff up—downright Shakespearean treachery unfolding at a feed machinery powerhouse! Muyang's courtroom escapades haven't exactly flown under the...

Continue Reading
Veteran Surge in 2026 Midterm Elections: A New Wave

Updated Category News Views 43

A Swell of Veteran Candidates Hits the Midterm Shores Just when you think you've seen it all in politics, here comes another twist. As the 2026 midterms gear up, an impressive 258 military veterans are throwing their hats into the congressional ring. That's a jump up from 213 just two years back, and let me tell you, it's not just a numbers game—it's a sea change. Women...

Continue Reading
Investcorp's Strong 2026: A Deep Dive into Key Moves

Updated Category News Views 139

Diving into Investcorp's Robust 2026 Performance If you're clued into the investment scene, you'll know that a $65.2 billion asset base isn't small potatoes. At the Gateway Gulf 2026, Investcorp didn't just present numbers—they laid out a dramatic year of action packed with billion-dollar dreams. While the dust hasn't quite settled yet, the first nine months of the year...

Continue Reading
Aosom Unveils Its Boldest Black Friday Extravaganza

Updated Category News Views 23

Black Friday Heat Kicks Off Early at Aosom All the seasoned shoppers out there smell a deal from a mile away, and Aosom isn't taking any chances by launching their Black Friday bash smack dab on November 2nd. This isn’t just any sale, it’s shaping up to be their most gigantic festival of discounts yet. Across Europe and North America, folks are rubbing their hands...

Continue Reading
2026 Rawlings Gold Glove Award Winners Announced

Updated Category News Views 142

Fielding Excellence on Display: The 2026 Rawlings Gold Glove Awards The Rawlings Gold Glove Awards have once again shone the spotlight on baseball's defensive maestros. Announced by Rawlings Sporting Goods Company, Inc., on November 1, 2026, this year's winners include 11 seasoned veterans and nine greenhorns who claimed their first-ever Gold Gloves. Unveiled during a...

Continue Reading
FFR Sets New Sales Record, Eyes Market Expansion

Updated Category News Views 98

FFR Breaks New Ground With Record Sales Something big's brewing at FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR), and it's causing quite the ripple. Picture this: 351 devices shipped in October alone. That's a hill-climbing record for this newbie on the U.S. stock scene. February was their starting line, and they've zoomed past 1,000 units in cumulative sales, chalking up...

Continue Reading
Navigating the Maze of Required Minimum Distributions

Updated Category News Views 197

Understanding Required Minimum Distributions Ever felt like retirement planning is walking a financial tightrope? Well, when it comes to Required Minimum Distributions (RMDs), you're tiptoeing on a wire. These IRS-mandated withdrawals aren't just accounting quirks; they’re a cornerstone of retirement income strategy—a fact unmistakably highlighted by Janie Kelly in...

Continue Reading

Top 5 Most Recently Viewed Articles

SkillWaze and Partners Create Pathway for Athlete Careers

Updated Category News Views 101

SkillWaze and Partners Create Pathway for Athlete Careers SkillWaze, known for its innovative AI-driven skill verification, has recently announced a game-changing partnership with Pangea Learning and Dynamic Athlete Placement (DAP). This strategic alliance aims to build a robust talent pipeline for student-athletes across over 500 prestigious universities. The goal is to...

Continue Reading
Welltower Plans Third Quarter Earnings Release and Call

Updated Category News Views 45

Welltower Announces Financial Results Conference Call Welltower® Inc. (NASDAQ: WELL) has recently made an important announcement regarding its upcoming third quarter 2024 financial results. The real estate investment trust (REIT), well-known for its driven transformation of health care infrastructure, will release its financial results after the close of trading on the...

Continue Reading
Catalyst Pharmaceuticals and Lupin Settle FIRDAPSE Patent Dispute

Updated Category News Views 178

Catalyst Pharmaceuticals and Lupin Settle FIRDAPSE Patent Dispute Located in Coral Gables, Fla., Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX) is excited to announce a significant development in the world of biopharmaceuticals. Recently, the company has reached a settlement with Lupin Pharmaceuticals regarding the patent litigation surrounding its drug FIRDAPSE®...

Continue Reading
Jim Chanos' Warning on Nvidia's Impact on AI Infrastructure

Updated Category News Views 230

Concerns about AI Hardware Debts Renowned short-seller Jim Chanos has raised critical concerns regarding the financial future of companies heavily investing in AI infrastructure, particularly Nvidia Corporation (NASDAQ: NVDA), CoreWeave Inc. (NASDAQ: CRWV), and Oracle Corporation (NYSE: ORCL). He suggests there is a severe financial risk linked to the use of aggressive...

Continue Reading
USBC Transitions to New Identity with Strategic Acquisition Success

Updated Category News Views 202

USBC, Inc. Embraces New Identity After Strategic Shift In a significant move, USBC, Inc. (NYSE: USBC) has successfully changed its name from Know Labs, Inc. This rebranding marks a new chapter in the Company's journey, especially following the strategic acquisition that recently took place. Effective immediately, USBC's stock will be traded under the ticker symbol "USBC"...

Continue Reading